outcomes of hodgkin lymphoma patients who receive a second asct
Published 5 years ago • 157 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:58
outcomes of patients with hodgkin lymphoma undergoing allohsct after pembrolizumab therapy
-
7:35
real-world analysis of hodgkin lymphoma outcomes after auto-sct
-
1:54
outcomes of classic hl, relapsed within one year of diagnosis, in the era of novel agents
-
1:11
improving outcomes in hodgkin lymphoma
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
5:01
relapsed & refractory classic hodgkin lymphoma
-
16:18
my stem cell transplant experience for hodgkin's lymphoma
-
16:55
i was in remission but my cancer came back a month later | sam's hodgkin's lymphoma relapse story
-
7:15
classic case: hodgkin's lymphoma
-
4:04
molecular characterization of classical hodgkin lymphoma
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
2:33
transplantation in hodgkin lymphoma in the context of targeted immunotherapy
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
1:06
molecules versus cells for hodgkin lymphoma management
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents